Cardiac alpha 1-adrenoceptors mediate positive inotropy via myofibrillar sensitization. 1992

M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
Laboratoire de Physiologie Cellulaire Cardiaque, INSERM U-241, Université Paris-Sud, Orsay, France.

UI MeSH Term Description Entries
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009210 Myofibrils The long cylindrical contractile organelles of STRIATED MUSCLE cells composed of ACTIN FILAMENTS; MYOSIN filaments; and other proteins organized in arrays of repeating units called SARCOMERES . Myofilaments,Myofibril,Myofilament
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D000316 Adrenergic alpha-Agonists Drugs that selectively bind to and activate alpha adrenergic receptors. Adrenergic alpha-Receptor Agonists,alpha-Adrenergic Receptor Agonists,Adrenergic alpha-Agonist,Adrenergic alpha-Receptor Agonist,Receptor Agonists, Adrenergic alpha,Receptor Agonists, alpha-Adrenergic,alpha-Adrenergic Agonist,alpha-Adrenergic Agonists,alpha-Adrenergic Receptor Agonist,Adrenergic alpha Agonist,Adrenergic alpha Agonists,Adrenergic alpha Receptor Agonist,Adrenergic alpha Receptor Agonists,Agonist, Adrenergic alpha-Receptor,Agonist, alpha-Adrenergic,Agonist, alpha-Adrenergic Receptor,Agonists, Adrenergic alpha-Receptor,Agonists, alpha-Adrenergic,Agonists, alpha-Adrenergic Receptor,Receptor Agonist, alpha-Adrenergic,Receptor Agonists, alpha Adrenergic,alpha Adrenergic Agonist,alpha Adrenergic Agonists,alpha Adrenergic Receptor Agonist,alpha Adrenergic Receptor Agonists,alpha-Agonist, Adrenergic,alpha-Agonists, Adrenergic,alpha-Receptor Agonist, Adrenergic,alpha-Receptor Agonists, Adrenergic
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
November 1986, Journal of molecular and cellular cardiology,
M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
October 1989, British journal of pharmacology,
M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
December 1985, Canadian journal of physiology and pharmacology,
M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
July 1993, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
January 1985, Journal of cardiovascular pharmacology,
M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
April 1990, Naunyn-Schmiedeberg's archives of pharmacology,
M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
December 1984, Brain research,
M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
October 1980, Canadian journal of physiology and pharmacology,
M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
July 1981, British journal of pharmacology,
M Pucéat, and A Terzic, and O Clément, and F Scamps, and S M Vogel, and G Vassort
October 1993, Cardiovascular research,
Copied contents to your clipboard!